Clik here to view.
World Vasectomy Day and DKT International Celebrate 10 Years Inspiring Men to...
WASHINGTON DKT International, one of the world’s largest providers of family planning, HIV/AIDS, and safe abortion products and services, is proud to continue its support of World Vasectomy Day...
View ArticleClik here to view.
Azura Ophthalmics Expands Broad Intellectual Property Portfolio to 12 U.S....
TEL AVIV, Israel & MELBOURNE, Australia Azura Ophthalmics Ltd., a clinical-stage biopharmaceutical company developing a new therapeutic class of Ophthalmic Keratolytics for ocular surface...
View ArticleClik here to view.
アビオメッドが高リスクPCI、心原性ショック、開心術後心原性ショックおよび右心不全に関するすべてのImpellaの市販後臨床試験が成功裏に完了したことを発表
米マサチューセッツ州ダンバース （ビジネスワイヤ） — アビオメッド（Nasdaq:...
View ArticleClik here to view.
デンタル・モニタリング、AI駆使型技術の力を活用したSmart STL*の提供を開始
パリ （ビジネスワイヤ） — デンタル・モニタリングは、AI駆使型技術の力を活用したSmart STL（スマートSTL）*の提供を開始しました。当社は、更新されたSTLファイルを100%リモートで作成できる口腔医療業界唯一のプラットフォームをもたらします*。この遠隔口腔医療技術の追加により、これまで不可能だった便利で費用対効果の高い方法で治療を提供できるよう臨床医をサポートします。...
View ArticleClik here to view.
BeiGene Expands Reach of its Innovative BTK Inhibitor with Recent Regulatory...
CAMBRIDGE, Mass., & BASEL, Switzerland & BEIJING BeiGene, (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company focused on developing innovative and affordable oncology...
View ArticleClik here to view.
Immunis Chairman Dr. Hans Keirstead Visits His Holiness the Dalai Lama
IRVINE, Calif. Immunis, Inc., a private biotech company developing a novel treatment for age and disease-related immune decline, announces that its Chairman, renowned neuroscientist Hans Keirstead,...
View ArticleClik here to view.
CANbridge Announces Encouraging Development in Maralixibat/LIVMARLI in Rare...
BEIJING & BURLINGTON, Mass. CANbridge Pharmaceuticals Inc. (HKEX:1228), a global biopharmaceutical company, with a foundation in China, committed to the research, development and...
View ArticleClik here to view.
Prestige Biopharma Group to Exhibit at CPhI Frankfurt 2022
SINGAPORE Prestige Biopharma group comprised of Prestige Biopharma Limited (950210: KRX) and Prestige Biologics Co., Ltd. (334970: KOSDAQ) is pleased to announce that it will be appearing at CPhI...
View ArticleClik here to view.
武田薬品工業：2022年度上期は力強い業績を達成、通期予想を上方修正
大阪 （ビジネスワイヤ） — 武田薬品工業株式会社（TOKYO：4502/NYSE：TAK）は、本日、2022年度上期の業績を公表しましたのでお知らせします。当社は財務ベースおよびCoreベースの通期予想、フリー・キャッシュ・フローを上方修正し、Core財務指標のCERベース での通期マネジメントガイダンスを維持します。 当社代表取締役社長CEOのクリストフ・ウェバー（Christophe...
View ArticleClik here to view.
Takeda Delivers Strong FY2022 H1 Results and Raises Full-Year Forecast
OSAKA, Japan Takeda (TOKYO:4502/NYSE:TAK) today announced financial results for the first half of fiscal year 2022 (period ended September 30, 2022), upgrading reported and core forecasts and free...
View ArticleClik here to view.
2seventy bio and JW Therapeutics Announce Strategic Partnership to Accelerate...
CAMBRIDGE, Mass. & SHANGHAI 2seventy bio, Inc. (Nasdaq: TSVT), a leading immuno-oncology cell therapy company, and JW Therapeutics (HKEX: 2126), an independent and innovative biotechnology...
View ArticleClik here to view.
Vizgen Announces International Expansion into Asia Pacific and EMEA
CAMBRIDGE, Mass. Vizgen, the life science company dedicated to improving human health by visualizing single-cell spatial genomics information, today announced the availability of its MERSCOPE™...
View ArticleClik here to view.
エクセンシアが第34回EORTC-NCI-AACR年次シンポジウムでGTAEXS-617による患者層別化とバイオマーカーに関する新規データを発表
オーストリア・ウィーン & 英オックスフォード （ビジネスワイヤ） — エクセンシア（Nasdaq:...
View ArticleClik here to view.
Exscientia在第34届EORTC-NCI-AACR年度研讨会上展示GTAEXS-617的新型患者分层和生物标志物数据
奥地利维也纳和英格兰牛津 (美国商业资讯)–Exscientia plc (Nasdaq: EXAI)今天公布了新的重要数据，旨在纳入更多有可能对其精确设计的CDK7抑制剂GTAEXS-617...
View ArticleClik here to view.
SYNLAB and Microba reinforce their combined expertise and expand strategic...
BRISBANE, Australia SYNLAB, the leader in medical diagnostic services and specialty testing in Europe, and Microba Life Sciences (Microba), a global leader in the analysis of complex gut...
View ArticleClik here to view.
武田发布强劲的2022财年上半年业绩并上调全年预期
日本大阪 (美国商业资讯)–武田(Takeda, TOKYO:4502/NYSE:TAK)今天公布了2022财年上半年（截至2022年9月30日的期间）的财务业绩，上调了本财年的报告和核心预测以及自由现金流展望，并重新确认了按恒定汇率(CER)计算的核心增长的管理层指引。 武田首席执行官Christophe Weber评论道：...
View ArticleClik here to view.
Clik here to view.
InnoCare Announces First Adolescent Patient Dosed in Clinical Trial of...
BEIJING InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the first adolescent patient...
View ArticleClik here to view.
Turnstone Biologics Announces FDA Clearance of IND for TIDAL-01, a...
SAN DIEGO Turnstone Biologics Corp, a clinical-stage biotechnology company developing next-generation immunotherapies to treat and cure solid tumors, today announced that the U.S. Food and Drug...
View ArticleClik here to view.
Exscientia荣获Prix Galien USA 2022数字健康解决方案大奖
英格兰牛津 (美国商业资讯)–Exscientia plc (Nasdaq: EXAI)荣幸地宣布，该公司凭借人工智能驱动的精准医疗平台赢得Prix Galien USA 2022“最佳数字健康解决方案”奖。该奖项于周四在纽约市的Prix Galien Forum上颁发。Prix Galien奖项在世界范围内表彰改善人类健康状况的卓越科学创新，是生物制药研究领域倍受瞩目的奖项。...
View Article